Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pathlore was a prominent provider of learning management systems (LMS) and business performance software, with a specialized focus on highly regulated industries such as healthcare and pharmaceuticals. The company's flagship platform was widely utilized by major pharmaceutical firms and over 100 hospital networks to manage regulatory compliance, including adherence to FDA 21 CFR Part 11 standards for electronic records. In addition to its software business, the name is associated with Pathlore Ltd, a specialist pathology service founded by renowned breast cancer expert Professor Ian Ellis, which provided expert histopathology and diagnostic services. Pathlore Software was acquired by SumTotal Systems in 2005, while the pathology division was integrated into Source BioScience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pathlore.